<DOC>
	<DOCNO>NCT02138097</DOCNO>
	<brief_summary>This protocol series descriptive analysis conduct within cohort patient use linagliptin , dipeptidyl peptidase-4 ( DPP-4 ) inhibitor , oral non-insulin injected hypoglycemic medication May 2011 July 2012 . Understanding 1 ) exist utilization pattern linagliptin , sitagliptin , saxagliptin , oral non-insulin injected hypoglycemic agent ( 2 ) difference utilization pattern agent help design , analysis interpretation comparative effectiveness safety study linagliptin , DPP-4 inhibitor , agent . The study provide overview exist utilization pattern linagliptin , dipeptidyl peptidase-4 ( DPP-4 ) inhibitor , oral non-insulin injected hypoglycemic agent , order detect potential selective prescribing pattern might lead channel bias .</brief_summary>
	<brief_title>Oral Non-insulin Injected Hypoglycemic Therapy Utilization Patterns</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Inclusion criterion : diagnosis type 2 diabetes mellitus dispense oral noninsulin inject hypoglycemic medication May 2011 June 2012 least 6 month enrolment database precede date first dispense Exclusion criterion : age &lt; 18 miss ambiguous age sex information least one diagnosis type 1 diabetes mellitus secondary diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>